Steven M. Weiner, M.D.

Transcription

1 Steven M. Weiner, M.D. EDUCATION University of Colorado, Denver, CO., 1983 M.D. University of Michigan, Ann Arbor, MI., 1978 B.S. in Chemistry and Cellular Biology Thesis: N.N -Diacetylcystine(DAC): A new antagonist of acetominophen (APAP) hepatotoxity in mice. Awards: Graduated Magna Cum Laude POSTGRADUATE TRAINING Ajust Transobturator Urethral Sling Course, 2011 Da Vinci Robotic Training Course, 2009 Niagra PV Surgical Laser Training Course, 2003 Pelvic Floor Reconstruction Course, 2002 TVT Cadaveric Training Course, 2002 Sacral Nerve Stimulator Implant Training Course, 2001 Proseed Prostate Brachytherapy Training Course, 2000 Indigo Diode Laser Training Course, 1998 Holmium YAG Laser Training Course, 1997 Transurethral Microwave Training Course, 1997 Laparoscopic Burch Colposuspension Training Course, 1997 Contigen Implant Training Course, 1993 Laparoscopy and Laparascopic Lymphadenectomy Training Course, 1991 Ultrasonography for Urologists Workshop, 1991 Lasers in Urology Workshop, 1991

2 Urology Resident, University of Colorado Health Sciences Center, Denver, Surgical Resident, University of Colorado Health Sciences Center, Denver, Surgical Intern, University of Colorado Health Sciences Center, Denver, PROFESSIONAL EXPERIENCE Urologist, Boulder Medical Center, Boulder, CO, Medical Director, Boulder Medical Center, Boulder, CO, Director, Ambulatory Surgery, Boulder Medical Center, Boulder, CO, Member, Board of Directors, Boulder Medical Center, Boulder, CO, , Buttonpusher, Kidney Stone Center of the Rocky Mountains, Clinical Instructor, Urology, University of Colorado Health Sciences Center, , Member, Clinical Advisory Board, Pfizer Pharmaceuticals, 1999-present Member, Hormone Refractory Prostate Cancer Advisory Board, Adventis Oncology, 2002-present. Chief, Surgical Services, Boulder Community Hospital, Boulder, CO, PROFESSIONAL ORGANIZATIONS American Association of Clinical Urologists American Lithotripsy Society American Urologic Association Wisconsin Medical Society Wisconsin Urologic Society PUBLICATIONS AND PAPERS Webber, M.M. Weiner, S.M., Rehman, S.M.M., and Wettlaufer, J.N.: Carcinoma of the prostate: Geographic distribution risk factors, In: In vitro models for cancer research, Vol.

3 V, Carcinomas of the prostate, testis, bronchus, and endothelial cell models, Webber, M.M. and Sekely, L.I., eds., CRC Press, Boca Raton, FL., Weiner, S.M. and Crawford, E.D.: Complications of retroperitoneal lymphadenectomy, In: Urologic Complications, 2 nd Ed., Smith, R.B., ed., Weiner, S.M. and Wettlaufer, J.N., Lymphocele: A rare complication of retroperitponeal lymphadenectomy-etiology, diagnosis, and management., RESEARCH Prostatic Ultrasound: Its role in the clinical management of prostate cancer.,1987 Transrectal fine needle aspiration cytology vs. tru-cut transperineal biopsy of the prostate in the diagnosis of prostate cancer., 1988 Long term effects of Finasteride (MK 906) in patients with BPH, The Proscar Study Group, MSD sponsors, A one-year, multicenter, double -blind comparison of the effects of once-daily dosing with three doses of SKF or placebo in the treatment of symptomatic BPH with six month untreated follow-up, SKF sponsors Long term safety with Alprostadil sterile powder (PGE1) in patients with erectile dysfunction, Roche sponsors, A three month double-blind, placebo controlled randomized, multicenter study of the effects and safety of SB S in patients with symptomatic BPH, SKB sponsors, 1995 A four week proof of concept study to determine the safety, tolerability and efficacy of oral SB in patients with symptoms of urinary urgency and frequency with or without incontinence, SKB sponsors, 1998 A phase III study of the efficacy and safety of ABT 980 in subjects with symptomatic BPH, ABT sponsors, 1998 A long-term open label extension trial evaluating the safety and efficacy of ABT-980 in subjects with BPH, ABT sponsors, 2000 A phase III Study evaluating the safety and efficacy of Uprima (Apomorphine HCl) (2,3 or 4 mg) compared to Viagra (Sildenafil Citrate) (25,50, or 100 mg) in the treatment of male erectile dysfunction, TAP sponsors, A phase III efficacy and safety study of M (Apomorphine HCl S.L.), TAP sponsors, A Randomized, Double-Blind, Multicenter, Phase III Study of Gatifloxacin and Ciprofloxacin in the Treatment of Chronic Bacterial Prostatitis, Bristol-Myers Squibb Co. sponsors, 1999

4 A four-week proof of concept study to determine the safety, tolerability and efficacy of oral SB in patients with symptoms of urinary urgency and frequency with or without incontinence., SmithKline Beecham, 2001 A multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Ibandronate to reduce skeletal-related morbidity due to bone metastasis in patients with hormone refractory prostate cancer, Roche Pharmaceuticals sponsors, 2001 A multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Ibandronate to reduce the risk of developing symptomatic bone metastasis in patients with hormone refractory prostate cancer, Roche Pharmaceuticals sponsors, 2001 An Open-Label Study to evaluate the Efficacy and Safety of Tadalafil Administered On Demand to men of Various Populations with Erectile Dysfunction, Lilly ICOS sponsors, 2003 PRESENTATIONS Transplant Immunology, Surgical Grand Rounds, UCHSC, May 1984 Stage B Prostate Cancer, Urology Grand Rounds, UCHSC, April, 1986 Stage B Bladder Cancer, Urology Grand Rounds, UCHSC, May 1986 Ureteroceles: Embryology, Anatomy, and Classification, Pediatric Urology Grand Rounds, The Children s Hospital, Denver, August 1986 Ureteral Complications of Gynecologic Surgery, Resident s Conference, UCHSC, August, Emphysematous Pyelonephritis, Resident s Conference, UCHSC, December, 1986 Complications of Ileoconduit Urinary Diversion, Resident s Conference, February, 1987 The TUR Syndromes, Resident s Conference, UCHSC, April, 1987 Explore All Scrotal Swellings-NO!, Surgical Grand Rounds, UCHSC, May 1987 PSA Significance in the Diagnosis of Prostate Cancer, BMC, November, 1988 Common Pediatric Urologic Problems, BMC, November, 1989 The Evaluation of Hematuria, BMC, August 1990 Urinary Incontinence-Diagnosis, Etiology, and Treatment, Nursing CME, Mapleton Rehabilitation Hospital, Boulder, April 1991 BPH-What s New, BMC, September, 1991

5 Urologic Problems in the Elderly, Frazier Meadows Nursing Home, February, 1992 Urologic Complications of Prostate Surgery-Recognition and Management, Nursing CME, BCH, Sept 1992 Impotence, BMC, October,1993 Urologic Update, BMC, September, 1994 BPH-Community Lecture, BCH, September, 1994 Prostate Cancer-Community Lecture, BCH, October, 1995 New Treatments of Urinary Incontinence, Flagstaff House, June, 2000 Levitra A New PDE5 Inhibitor, Boulder Medical Center, October, 2003 Levitra A New PDE5 Inhibitor, Broomfield Family Practice, November, 2003 Avodart in the management of BPH, multiple lectures, The Management of Localized Prostate Cancer, Community Lecture, 2010 VOLUNTEER ACTIVITY Free Prostate Cancer Screenings, BCH, Free Prostate Cancer Screenings, Valley Labs, Sex Education for Preadolescent Boys, Niwot Elementary School, Mitzvah Day, Congregation Har Hashem, HOSPITAL AFFILIATIONS AND PROFESSIONAL LISCENSURE Aurora Lakeland medical Center, Elkhorn, WI, Active Aurora Burlington Memorial Hospital, Burlington, WI, Active Aurora Medical Center, Summit, Courtesy Board Certified American Board of Urology, February, 1990, Certificate #9934 Recertified American Board of Urology, February, 2000, Certificate # 9934

6 Recertified American Board of Urology, Febreuary, 2010, Certificate #9934 Licensed to practice Medicine in Colorado and Wisconsin. Updated 4/4/2011